MARIA ISABEL
LOPEZ GALVEZ
Investigadora en el periodo 1995-2022
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (7)
2022
-
A Screening Tool for Self-Evaluation of Risk for Age-Related Macular Degeneration: Validation in a Spanish Population
Translational Vision Science and Technology, Vol. 11, Núm. 6
2021
-
Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema
Cells, Vol. 10, Núm. 7
-
Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study
Acta ophthalmologica, Vol. 99, Núm. 8, pp. 861-870
-
Signature of circulating biomarkers in recurrent non-infectious anterior uveitis. Immunomodulatory effects of dha-triglyceride. a pilot study
Diagnostics, Vol. 11, Núm. 4
2020
-
Clinical and molecular-genetic insights into the role of oxidative stress in diabetic retinopathy: Antioxidant strategies and future avenues
Antioxidants, Vol. 9, Núm. 11, pp. 1-19
2015
-
Enhanced Oxidative Stress and Other Potential Biomarkers for Retinopathy in Type 2 Diabetics: Beneficial Effects of the Nutraceutic Supplements
BioMed Research International, Vol. 2015
-
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
Journal of Ophthalmology, Vol. 2015